We are live on ! Find out more
PLSE icon

Pulse Biosciences

45 hedge funds and large institutions have $32.4M invested in Pulse Biosciences in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

21% more capital invested

Capital invested by funds: $26.8M → $32.4M (+$5.61M)

7% more funds holding

Funds holding: 4245 (+3)

0.21% more ownership

Funds ownership: 9.9%10.1% (+0.21%)

Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
14
Reduced
9
Closed
Calls
$332K
Puts
Net Calls
+$332K
Net Calls Change
-$1.08M

PLSE Hedge Fund Activity: Q3 2019 in Review

45 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2019, worth a combined $32.4M — up 21% from $26.8M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PLSE positions and 0 closed out — a net gain of 4 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $262K. The largest seller was Griffin Asset Management, cutting an estimated $121K.

  • 45 institutional investors held Pulse Biosciences (PLSE) as of Q3 2019, up from 42 in Q2 2019.
  • Funds reported $32.4M of Pulse Biosciences stock for Q3 2019, up 21% quarter-over-quarter.
  • 4 funds opened new Pulse Biosciences positions in Q3 2019 and 0 closed out, a net change of +4 holders.
  • The largest Pulse Biosciences buyer in Q3 2019 was BlackRock, an estimated $262K added.
  • The largest Pulse Biosciences seller in Q3 2019 was Griffin Asset Management, an estimated $121K sold.

Based on aggregated 13F filings for Q3 2019.